Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation (NCT03961256)Mayo Clinic2019-05-09
Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL) (NCT04554485)Institute of Hematology and Blood Transfusion, Czech Republic2019-05-09
Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection (NCT03762473)University of Alabama at Birmingham2019-05-09
A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before (NCT03951805)Novo Nordisk A/S2019-05-09
A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma (NCT03758989)University of Rochester2019-05-08
Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCC (NCT04268888)The Clatterbridge Cancer Centre NHS Foundation Trust2019-05-08
Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection (NCT03991780)Imperial College London2019-05-08
AZD1775 in Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myelofibrosis (NCT03718143)NYU Langone Health2019-05-08
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia (NCT03739814)National Cancer Institute (NCI)2019-05-08
Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients With Apparent Risk Factors of NASH (NCT05343780)Natural Wellness Egypt2019-05-08
Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer (NCT04192682)Changzhou Cancer Hospital of Soochow University2019-05-08
Phase 2/3 Study of ALK-001 in Geographic Atrophy (NCT03845582)Alkeus Pharmaceuticals, Inc.2019-05-07
Safety, Immunogenicity and Efficacy of R21 Matrix-M in 5-17 Month Old Children in Nanoro, Burkina Faso (NCT03896724)University of Oxford2019-05-07
First-in-Patient Study for Sing le Dose of M201-A Hydrochloride Injection in Japanese Patients With Paroxysmal Atrial Fibrillation (NCT04609059)Kitasato University2019-05-07
Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis (NCT03198689)London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2019-05-07
PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer (NCT02917005)Hamdy A. Azim2019-05-07
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors (NCT03645928)Iovance Biotherapeutics, Inc.2019-05-07
To Share Or Not To Share (NCT03943862)University of Ulm2019-05-07
Atezolizumab in Advanced Non-small Cell Lung Cancer With Rare Histologies (CHANCE Trial) (NCT03976518)Gruppo Oncologico Italiano di Ricerca Clinica2019-05-07
Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors (NCT03781778)Fred Hutchinson Cancer Center2019-05-07
Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 - (NCT03819010)MedSIR2019-05-07
Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA (NCT03544099)National Health Research Institutes, Taiwan2019-05-07
A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy (NCT03905512)Selecta Biosciences, Inc.2019-05-07
Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy (NCT03819114)Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections2019-05-06
Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal Cancer (NCT03957902)Instituto de Investigación Sanitaria Aragón2019-05-06
Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1 (NCT04246723)R-Pharm2019-05-06
Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders (NCT03937661)Genesis Athens Clinic2019-05-06
Homeopathy for Overweight and Obesity in Mexican Adolescents (NCT03945396)Hospital Juarez de Mexico2019-05-06
Neoadjuvant PD-1 Blockade in Patients with Stage IIB/C Melanoma (NCT03757689)Abramson Cancer Center at Penn Medicine2019-05-06
The Efficacy and Safety of Sirolimus for Plastic Bronchitis (NCT03942926)Peking Union Medical College Hospital2019-05-06
Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia (NCT03705286)Yale University2019-05-06
Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida (NCT03961360)The University of Texas Health Science Center, Houston2019-05-06
Evaluation of Treatment Option for Demodicosis in Patients Undergoing Cataract Surgery (NCT04204954)Hospital de La Luz2019-05-06
Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV (NCT03837756)University of Aarhus2019-05-06
TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma:RCT (NCT03741244)The Second Hospital of Hebei Medical University2019-05-06
Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis (NCT03893565)GlaxoSmithKline2019-05-06
KN046 in Patients With Advanced Non-small Cell Lung Cancer (NCT03838848)Jiangsu Alphamab Biopharmaceuticals Co., Ltd2019-05-05
GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCT (NCT03911037)Post Graduate Institute of Medical Education and Research, Chandigarh2019-05-04
Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer (NCT03781323)University of Rochester2019-05-03
Pembrolizumab in Treating Participants With Leukoplakia (NCT03603223)Jonsson Comprehensive Cancer Center2019-05-03
Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms (NCT03549650)Sir Mortimer B. Davis - Jewish General Hospital2019-05-03
Establishing the Recommended Biological Dose for AE37 Peptide Vaccine in Combination With Pembrolizumab That Will Enhance the Tumor-specific Immune Response and Demonstrate Efficacy in Patients With Advanced Triple-negative Breast Cancer (NCT04024800)NuGenerex Immuno-Oncology2019-05-03
Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery (NCT03604991)National Cancer Institute (NCI)2019-05-03
NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer (NCT03734809)Chinese University of Hong Kong2019-05-03
Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism (NCT04648969)Stephanie B. Seminara, MD2019-05-03
Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy (NCT03832660)Newcastle University2019-05-03
Treating PCOS With Semaglutide vs Active Lifestyle Intervention (NCT03919929)University of Colorado, Denver2019-05-03
Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device (NCT03925324)Medstar Health Research Institute2019-05-03
Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC) (NCT03742986)NYU Langone Health2019-05-02
Combination Chemotherapy in Patients With Newly Diagnosed BPDCN (NCT03599960)Centre Hospitalier Universitaire de Besancon2019-05-02
Study of Lorlatinib in ROS1 Rearranged NSCLC (NCT03612154)National Cancer Center, Korea2019-05-02
CAcTUS - Circulating Tumour DNA Guided Switch (NCT03808441)The Christie NHS Foundation Trust2019-05-02
Pubalgia and Adductor Tendinopathies Refractory to Medical Treatment (NCT03496649)University Hospital, Bordeaux2019-05-02
Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients (NCT04013646)Bundang CHA Hospital2019-05-02
Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC (NCT03899428)Humanity & Health Medical Group Limited2019-05-02
A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone (NCT03909152)Memorial Sloan Kettering Cancer Center2019-05-02
Sleep Disordered Breathing With Opioid Use (NCT05589753)VA Office of Research and Development2019-05-02
Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and Epacadostat (NCT03823131)Chase Heaton, MD2019-05-02
Focal Intraoperative Radiotherapy of Brain Metastases (NCT03789149)AC Camargo Cancer Center2019-05-02
TAPS2 Transfusion Antenatally in Pregnant Women With SCD (NCT03975894)Guy's and St Thomas' NHS Foundation Trust2019-05-02
Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use (NCT02870218)Rose Research Center, LLC2019-05-01
The Effect of Donepezil in Radiotherapy-related Cognitive Impairment. (NCT03907371)Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University2019-05-01
Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma (NCT03915132)Chinese Academy of Medical Sciences2019-05-01
Annexin Imaging in Dissection of the Descending Aorta (NCT03832582)Assistance Publique - Hôpitaux de Paris2019-05-01
Single Escalating Dose Pilot Trial of Canakinumab (ILARIS®) in Duchenne Muscular Dystrophy (NCT03936894)Children's National Research Institute2019-05-01
Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic Cancer (NCT03885219)Peking Union Medical College Hospital2019-05-01
Treatment of Moderate Hidradenitis Suppurativa (NCT03910803)Florida Academic Dermatology Centers2019-05-01
Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer (NCT04027764)Dai, Guanghai2019-05-01
Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer (NCT03892642)University of Oklahoma2019-05-01
Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer (NCT03764553)Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2019-05-01
A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar Ichthyosis (NCT03738800)Mayne Pharma International Pty Ltd2019-05-01
Triple or Quadruple Combination DAAs Treatment for Subjects With HCV GT 1b Infection (NCT03794258)Humanity & Health Medical Group Limited2019-05-01
Candesartan in Peripheral Neuropathy (NCT03688633)University Hospital, Limoges2019-05-01
Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I) (NCT03684278)University of Liverpool2019-05-01
Study Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD (NCT03937479)Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA2019-05-01
IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma. (NCT03854838)Sun Yat-sen University2019-05-01
A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in Eltrombopag-inefficient or Relapsed ITP (NCT03754634)Shandong University2019-05-01
Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC (NCT03634332)Pancreatic Cancer Research Team2019-05-01
Neurosteroids for PTSD in Veterans (NCT03799562)VA Office of Research and Development2019-05-01
IC14 in Adult Patients With Dengue Fever (NCT03875560)Implicit Bioscience2019-05-01
Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer (NCT03348631)National Cancer Institute (NCI)2019-05-01
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases (NCT04343157)Jona Hattangadi-Gluth2019-05-01
Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease (NCT03808103)Intralytix, Inc.2019-05-01
IVIG-eye Drops Treatment for Dry Eye Disease (NCT03992482)Sandeep Jain, MD2019-05-01
Beneficial Effect of Intravenous Magnesium Sulphate in Term Neonates With Hypoxic Ischemic Encephalopathy(HIE) (NCT04705142)Services Institute of Medical Sciences, Pakistan2019-05-01
A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome (NCT03931785)Ironwood Pharmaceuticals, Inc.2019-05-01
Improve Checkpoint-blockade Response in Advanced Urothelial Cancer (NCT03871036)The Netherlands Cancer Institute2019-05-01
Fasting-mimicking Diet and Immunosenescence (NCT02554188)University of Southern California2019-05-01
Fit for Surgery. Multimodal Prehabilitation in Colorectal Cancer Patients (NCT04167436)Zealand University Hospital2019-05-01
Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer (NCT04267549)Tianjin Medical University Cancer Institute and Hospital2019-05-01
Pharmacokinetics, Safety and Tolerability of Fevipiprant Delivered Via a Once Daily Chewable Tablet in Children Aged 6 to < 12 Years With Asthma (NCT03650400)Novartis Pharmaceuticals2019-05-01
A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer (NCT04009876)Fundación de investigación HM2019-05-01
Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors (NCT05809336)Beijing Friendship Hospital2019-05-01
Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma (NCT04047693)Pusan National University Yangsan Hospital2019-05-01
Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and Desensitization (NCT03805178)Duke University2019-05-01
Triple Therapy in T1DM (NCT03899402)State University of New York at Buffalo2019-05-01
SOX-based CRT for Esophageal Cancer. (NCT03991104)Zhejiang Provincial People's Hospital2019-05-01
Clinical Research of Adoptive BCMA CAR-NK Cells on Relapse/Refractory MM (NCT03940833)Asclepius Technology Company Group (Suzhou) Co., Ltd.2019-05-01
ASSET 2 Study: Long-Term Follow-up of a Randomised Control Trial (NCT04022629)Royal Infirmary of Edinburgh2019-05-01
Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer (NCT03850769)Peking Union Medical College Hospital2019-05-01
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.